Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • 303-18: Brain Stimulation & Neuromodulation

    Contains 5 Component(s), 1.00 credit offered

    Presenter: Donna Ecklesdafer, MSN, RN - 1.0 contact hours

    303-18:  Brain Stimulation & Neuromodulation

    This presentation explains how different kinds of brain stimulation and neuromodulation continue be effective as alternative or first line therapy for a variety of psychiatric illnesses. These treatments are offered as an option for people for whom psychiatric medications are not effective or are not indicated.


    Presenter:
      Donna Ecklesdafer, MSN, RN

    Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label uses will not be discussed during this presentation.


    Session Length:
      1 hour 11 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Identify modalities of brain stimulation.
    2. Examine the vital role of the PMH nurse in all phases of care in brain stimulation and research.

    Keywords:  TMS, ECT, Practice


    Continuing Nursing Education:
    1.0 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 16th Annual Clinial Psychopharmacology Institute
    Baltimore, Maryland
    Sunday, June 10, 2018
    12:15pm - 1:45pm

    The contact hours for this session expire: December 31, 2020

  • 301-18: Naming, Framing, and Containing the Physiology of Fear – A Wellness Approach

    Contains 5 Component(s), 1.25 credits offered

    Presenter: Mary D. Moller, DNP, PhD, ARNP, PMHCNS-BC, CPRP, FAAN - 1.25 pharmacology contact hours

    301-18: Naming, Framing, and Containing the Physiology of Fear – A Wellness Approach 

    This presentation uses a case study to explain how experience of trauma leads to symptoms, based on fear and triggered responses, causing changes in the chemistry of the brain. Careful patient centered assessments in the context of culture, spiritual beliefs, and life history can measure psychiatric wellness for improved outcomes.


    Presenter:
      Mary D. Moller, DNP, PhD, ARNP, PMHCNS-BC, CPRP, FAAN

    Disclosures: The speaker has indicated a significant financial interest or other affiliation with Alkermes Pharmaceutical-Aristada Lauroxil (speakers bureau). Presenter is the co-author of the Murphy Moller Wellness Model used in this presentation. Off-label uses will not be discussed during this presentation. The activity planners have no conflicts of interest to disclose.


    Session Length:
     1 hour 21 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Discuss the biopsychosocialspiritual consequences of fear on information processing and the development of trauma responses.
    2. Identify wellness strategies to decrease the impact of fear and fear triggers on activities of daily living.

    Keywords:  Fear, APRN Practice, Trauma, Psychopharmacology


    Continuing Nursing Education:
    1.25 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 16th Annual Clinical Psychopharmacology Institute
    Baltimore, Maryland
    Sunday, June 10, 2018
    8:00am - 9:30am

    The contact hours for this session expire: December 31, 2020

  • 302-18: Psychotropic Medications & Impact on the Bone

    Contains 5 Component(s), 1.00 credit offered

    Presenter: Karen L. Houseknecht, PhD - 1.0 pharmacology contact hours

    302-18:  Psychotropic Medications & Impact on the Bone

    This researcher explains how preliminary research demonstrates a negative effect of serotonin on bone health.  While the use of antipsychotic and antidepressant medications may have harmful side effects on bone, there are new ideas of how to mitigate this risk.


    Presenter:
      Karen L. Houseknecht, PhD

    Disclosures: The presenter and planners have no conflict of interest or commercial support to disclose. Off-label uses will be discussed during this presentation.


    Session Length:
     1 hour 2 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Describe the pharmacology underlying effects of psychotropic medications on metabolic and bone health.
    2. Explore the impact of off-label prescribing on metabolic burden and bone health in patients taking antipsychotic medications.

    Keywords: Bone Health, APRN Practice, Psychopharmacology, Serotonin


    Continuing Nursing Education:
    1.0 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 16th Annual Clinical Psychopharmacology Institute
    Baltimore, Maryland
    Sunday, June 10, 2018
    9:45am - 11:15am

    The contact hours for this session expire: December 31, 2020

  • 204-18: Shared Decision Making in Pharmacotherapy Management

    Contains 5 Component(s), 1.75 credits offered

    Presenter: Mary A. Gutierrez, PharmD, BCPP - 1.75 pharmacology contact hours

    204-18:  Shared Decision Making in Pharmacotherapy Management

    Moving away from the old concepts of compliance or adherence, this presentation provides an insightful discussion of influences on a patients’ self-management of their illness. The participant will gain perspective on how providers can achieve a successful decision making partnership with their patient.


    Presenter:
      Mary A. Gutierrez, PharmD, BCPP

    Disclosures: The presenter and planners have no conflict of interest or commercial support to disclose. Off-label uses will be discussed during this presentation.


    Session Length:
      1 hour 44 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Identify factors that pose challenges for patients in effective self-management of medications.
    2. Identify strategies to avoid or minimize psychiatric medications' adverse drug effects and interactions.

    Keywords: APRN Practice, Medication Management, Psychopharmacology


    Continuing Nursing Education:
    1.75 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 16th Annual Clinical Psychopharmacology Institute
    Baltimore, Maryland
    Saturday June 9, 2018
    1:45pm - 3:45pm

    The contact hours for this session expire: December 31, 2020

  • 202-18: Military Psychiatry: Practice and Pitfalls - A Case Study Analysis

    Product not yet rated Contains 5 Component(s), 1.50 credits offered

    Presenter: Joseph M. Holshoe, PMHNP-BC - 1.50 contact hours

    202-18:  Military Psychiatry: Practice and Pitfalls - A Case Study Analysis

    This presentation explains how the context of military structure and the roles of the provider and patient may influence the provision of psychiatric mental health services. Then case studies help the audience to apply this knowledge in decision making related to “fit for duty” decisions.


    Presenter:
      Joseph M. Holshoe, PMHNP-BC

    Disclosures: The presenter and planners have no conflict of interest or commercial support to disclose. Off-label uses will be discussed during this presentation.


    Session Length:
      1 hour 31 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Increase knowledge of deployment- and service-limiting behavioral health diagnoses.
    2. Expand knowledge of common variances in behavioral health diagnoses in the military population.

    Keywords:  Military, APRN Practice


    Continuing Nursing Education:
    1.50 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 16th Annual Clinical Psychopharmacology Institute
    Baltimore, Maryland
    Saturday June 9, 2018
    9:45am - 11:15am

    The contact hours for this session expire: December 31, 2020

  • 201-18: The Amazing Teen Brain

    Contains 5 Component(s), 1.50 credits offered

    Presenter: Jay N. Giedd, MD - 1.50 contact hours

    201-18:  The Amazing Teen Brain

    This presentation explains the vulnerabilities and the great opportunities of the developing adolescent brain. Current brain research using PET and fMRI scanning helps us to understand the process of arborization and pruning as the brain develops from infancy into young adulthood, and why certain well known behaviors appear when they do.


    Presenter:
      Jay N. Giedd, MD

    Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label uses will not be discussed during this presentation.


    Session Length:
     1 hour 25 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Identify the key characteristics of the teen brain underlying the vulnerability to illness and the opportunity for intervention.
    2. Identify a key difference between Neanderthals and humans that facilitated the survival or our species.

    Keywords: Child & Adolescent, Research


    Continuing Nursing Education:
    1.50 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 16th Annual Clinical Psychopharmacology Institute
    Baltimore, Maryland
    Saturday June 9, 2018
    8:00am - 9:30am

    The contact hours for this session expire: December 31, 2020

  • 205-18: Developing Clinical Targets through PET Imaging: Dementia and Depression

    Product not yet rated Contains 5 Component(s), 1.25 credits offered

    Presenter: Robert Innis, MD, PhD 1.25 contact hours

    205-18:  Developing Clinical Targets through PET Imaging: Dementia and Depression

    This presentation describes the use of uniquely prepared ligands for PET imaging, which is changing how we understand the neuroscience of addictions.


    Presenter:
      Robert Innis, MD, PhD

    Disclosures:  NIMH received research support from Janssen Pharmaceuticals to conduct the study of neuroinflammation in depression. The planners have no conflict of interest or commercial support to disclose.  Off-label uses will not be discussed during this presentation.


    Session Length:
     1 hour 13 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Discuss the science of PET scanning related to treatment of psychiatric disorders.
    2. Relate the use of PET scanning to understanding inflammation in diseases of the brain and associated symptom manifestation. 

    Keywords:  Research, Older Adults, Mental Health Conditions


    Continuing Nursing Education:
    1.25 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 16th Annual Clinical Psychopharmacology Institute
    Baltimore, Maryland
    Saturday, June 9, 2018
    4:00pm - 5:30pm

    The contact hours for this session expire: December 31, 2020

  • 104-18: Legal Issues in Prescribing

    Contains 5 Component(s), 1.50 credits offered

    Presenter: Carolyn Buppert, MSN, JD - 1.50 pharmacology contact hours

    104-18:  Legal Issues in Prescribing 

    As a nurse practitioner and attorney, Carolyn Buppert explains multiple situations in prescribing that could lead to licensing and legal problems for APRNs. Case-based examples provide practicing pitfalls and practical guidance for managing risk as a prescriber. Current best practices in prescribing opioids is discussed.


    Presenter:
      Carolyn Buppert, MSN, JD

    Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label uses will not be discussed during this presentation.


    Session Length:
      1 hour 26 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Describe things an advance practice clinician should never, and should always do when prescribing.
    2. Analyze the legal risks of 3 common prescribing practices.

    Keywords:  Legal, APRN Practice, Psychopharmacology


    Continuing Nursing Education:
    1.50 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 16th Annual Clinical Psychopharmacology Institute
    Baltimore, Maryland
    Friday, June 8, 2018
    2:15pm - 3:45pm

    The contact hours for this session expire: December 31, 2020

  • 101-18: Marijuana Science Update

    Contains 5 Component(s), 1.50 credits offered

    Presenter: Wilson M. Compton, MD, MPE - 1.50 pharmacology contact hours

    101-18:  Marijuana Science Update

    This presentation provides a broad summary of current research findings related to long and short-term use of marijuana. Prevalence, risks, and effects of marijuana use across the lifespan are discussed with a special focus on the developing adolescent brain. Medical uses of marijuana/cannabinoids are also discussed.


    Presenter:
      Wilson M. Compton, MD, MPE

    Disclosures: The speaker has indicated a significant financial interest or other affiliation with Pfizer, 3M, and General Electric (Stock).  Off-label uses will not be discussed during this presentation. The activity planners have no conflicts of interest to disclose.


    Session Length:
      1 Hour 30 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Discuss the wide ranging short and long-term effects related to the use of marijuana on an individual’s brain, body and behavior.
    2. Explore recent studies of the impact of marijuana on the developing adolescent brain.

    Keywords:  Child & Adolescent, Substance Use, Research, Psychopharmacology


    Continuing Nursing Education:
    1.50 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


    Originally Presented
    APNA 16th Annual Clinical Psychopharmacology Institute
    Baltimore, Maryland
    Friday, June 8, 2018
    8:00am - 9:30am

    The contact hours for this session expire: December 31, 2020

  • Novel Treatments to Overcome Clinical Challenges in Treating Major Depressive Disorder

    Contains 7 Component(s), 1.25 credits offered

    Presenters: Patricia Cunningham, DNSc, APRN-BC; Patrick R. Finley, PharmD, BCPP 1.25 pharmacology contact hours

    Novel Treatments to Overcome Clinical Challenges in Treating Major Depressive Disorder

    Despite a number of distinct medication classes, only one-third of patients with major depressive disorder (MDD) achieve remission with initial antidepressant therapy, and a substantial number of patients fail to achieve remission after as many as four acute treatment trials. Furthermore, many patients who respond to antidepressant therapy may experience residual symptoms that negatively affect their quality of life and increase the likelihood of relapse. There are a number of treatment strategies for managing patients with difficult-to-treat depression, treatment-resistant depression, and residual symptoms of depression; a number of these strategies include agents of novel, unconventional mechanisms of action. This archived live symposium will highlight recently approved and investigational agents for treating patients with MDD along with novel approaches to individualized therapy. Nurse and pharmacist-driven strategies to maintain MDD treatment goals and optimize patient outcomes will also be discussed. 

    Steering Committee:
    Patricia Cunningham, DNSc, APRN-BC
    Associate Professor
    Arkansas State University
    Jonesboro, Arkansas

    Patrick R. Finley, PharmD, BCPP
    Professor of Clinical Pharmacy
    School of Pharmacy
    University of California at San Francisco
    San Francisco, California

    Disclosures:
    • The Nurse Planner and members of the planning committee have no financial relationships to disclose.
    • Dr. Cunningham reports having no relevant financial or advisory relationships with corporate organizations related to this activity.
    • Dr. Finley reports having no relevant financial or advisory relationships with corporate organizations related to this activity.

    Session Length:  1 Hour 2 minutes

    Target Audience:  RN, APRN


    Learning Outcomes:
    Upon completion of this presentation, the participant will be able to:

    1. Describe recently approved antidepressants and other novel treatments and their implications in treating MDD.
    2. Discuss practical strategies that incorporate novel approaches to individualized MDD therapy.
    3. Implement nurse-driven pharmacist-driven approaches to work with patients and one another to attain and maintain MDD treatment goals.

    Keywords:  Depression, Pharmacology, Advance Practice


    Continuing Nursing Education:
    1.25 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to the presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

    The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Accreditation of the continuing education activity does not imply endorsement by APNA or ANCC of any commercial products discussed in the context of this activity. 

    Support for the Program:
    This program is supported through educational grants from Alkermes, Takeda Pharmaceuticals U.S.A., Inc, and Lundbeck.


    Table of Contents
    Activity Overview
    Pre-assessment 
    Major Depressive Disorder
    Novel Treatments for MDD 
    Conclusions, Post-assessment, and Evaluation

    Pricing: Free

    Release Date: January 4, 2018
    The contact hours for this session expire:  January 4, 2019